This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
News|Articles|September 29, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-10-05-2016
- Volume 11
- Issue 10
STERIS Launches Glassware Washer
Author(s)Pharmaceutical Technology Editors
STERIS launched the Reliance 300XLS Laboratory Glassware Washer, adding to the company’s line of glassware and plasticware washing systems.
Advertisement
On Sept. 19, 2016, STERIS Corporation announced the addition of the Reliance 300XLS Laboratory Glassware Washer to its line of laboratory glassware and plasticware washing systems. This new system is designed to help STERIS better address customers’ specific automated washing needs. The 300XLS uses 40% less square feet of floor space than STERIS’s 400XLS Laboratory Glassware Washer.
The Reliance 300XLS Laboratory Glassware Washer includes a color touch screen microprocessor control system and several pre-set, user-definable cycles to accommodate the various soil conditions encountered in typical laboratories. The four-level guiding rail system, combined with a wide variety of loading accessories, provides all the flexibility required to simultaneously process small and large pieces of glassware, maximizing the use of the wash chamber.
Source: STERIS
Articles in this issue
about 10 years ago
Researchers Identify a Greener Fluorination Reactionabout 10 years ago
Contract Manufacturers Match Capabilities to Market Needsabout 10 years ago
Looking for a Root Cause of Parenteral Contaminantsabout 10 years ago
API Manufacturers Compete through Process Optimizationabout 10 years ago
Mettler Toledo Launches New Liquid Handling Platformabout 10 years ago
Onset Expands Product Line for Cold-Chain Monitoringabout 10 years ago
BASF Opens PVP Facility in Shanghaiabout 10 years ago
Contract Packager Expands Serialization and Cold Chain Capabilitiesabout 10 years ago
PCI to Expand Bridgend Facilityabout 10 years ago
PYRAMID Laboratories Gets Clean FDA InspectionAdvertisement
Related to this article
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Advertisement
Advertisement